— Know what they know.
Not Investment Advice

VNRX AMEX

VolitionRX Ltd
1W: -9.3% 1M: -37.6% 3M: -82.6% YTD: -13.9% 1Y: -62.2% 3Y: -67.6% 5Y: -92.8%
$0.23
+0.00 (+0.13%)
 
Weekly Expected Move ±9.8%
$0 $0 $0 $0 $0
AMEX · Healthcare · Medical - Devices · Tech Score Sell · Power 35 · $2.0M mcap · 7M float · 89.60% daily turnover · Short 42% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.0M
52W Range0.23-13.4
Volume1,360,274
Avg Volume5,963,370
Beta1.09
Dividend—
Analyst Ratings
5 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEOCameron Reynolds
Employees57
SectorHealthcare
IndustryMedical - Devices
IPO Date2012-03-02
1489 West Warm Springs Road
Henderson, NV 89014
US
646 650 1351
About VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Recent Insider Trades

NameTypeSharesPriceDate
Forterre Gael F-InKind 284 $0.25 2026-09-28
Michel Gaetan F-InKind 608 $0.25 2026-09-28
Forterre Gael F-InKind 5,251 $0.19 2026-03-17
Rootsaert Rodney Ger F-InKind 3,948 $0.19 2026-03-17
Micallef Jacob Vince F-InKind 5,310 $0.19 2026-03-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms